- Report
- November 2025
- 50 Pages
Global
From €2377EUR$2,650USD£2,096GBP
Paliperidone is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. It is an atypical antipsychotic drug, meaning it works differently than traditional antipsychotics. Paliperidone works by blocking certain receptors in the brain, which helps to reduce symptoms of mental illness. It is available in both oral and injectable forms.
Paliperidone is a relatively new drug, having been approved by the FDA in 2006. It is generally well-tolerated and has fewer side effects than other antipsychotics. It is also effective in treating both positive and negative symptoms of mental illness.
The Paliperidone market is highly competitive, with many companies offering the drug. Some of the major players in the market include Johnson & Johnson, Novartis, Teva Pharmaceuticals, and Mylan. Other companies such as Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Intas Pharmaceuticals also offer Paliperidone. Show Less Read more